Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SEASON South East Asian Study Of Novel Genotypes in Hepatitis C Infection: Pegylated-interferon and ribavirin therapy (PEGATRON REDIPEN combination therapy (PEG-Intron(R) REDIPEN Plus REBETOL(R))) in treatment naive patients With genotypes 1, 6, 7, 8, 9: A comparison of race and genotype on treatment outcome

Next Previous
X
Search
Trial Profile

SEASON South East Asian Study Of Novel Genotypes in Hepatitis C Infection: Pegylated-interferon and ribavirin therapy (PEGATRON REDIPEN combination therapy (PEG-Intron(R) REDIPEN Plus REBETOL(R))) in treatment naive patients With genotypes 1, 6, 7, 8, 9: A comparison of race and genotype on treatment outcome

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 06 May 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Peginterferon alfa-2b/ribavirin (Primary) ; Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms SEASON
  • Sponsors Merck Sharp & Dohme Corp.

    • Most Recent Events

    • 12 Jan 2010 Actual end date (Dec 2007) and actual noumber of patients (121) added as reported by ClinicalTrials.gov.
    • 12 Jan 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 26 Mar 2008 The expected completion date for this trial is now 1 Dec 2007, as reported by clinicaltrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top